Markets
Stocks
Mutual Funds & ETFs
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Teva Pharmaceutical Industries (NY: TEVA)
40.06 USD  +0.41 (+1.04%)
Streaming Delayed Price  /  Updated: 11:59 AM EST, Dec 9, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,189,334
Open 39.71
Bid (Size) 40.06 (800)
Ask (Size) 40.07 (1100)
Prev. Close 39.65
Today's Range 39.34 - 40.07
52wk Range 36.26 - 42.83
Shares Outstanding 845,000,000
Dividend Yield 2.42%
Performance
YTD
+7.72%
+7.72%
1 Month
+8.24%
+8.24%
3 Month
+4.93%
+4.93%
6 Month
+0.15%
+0.15%
1 Year
-5.56%
-5.56%
Top News
More News
Teva to Host 2014 Business Outlook Conference Call and Webcast on December 10, 2013
December 04, 2013
from Business Wire News Releases
Teva In-Focus: A Webinar Series for the Investment Community Focusing on Teva’s R&D Activities
December 04, 2013
from Business Wire News Releases
More News
Read More
Teva and Takeda Announce Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
December 04, 2013
from Business Wire News Releases
“Dancing with the Stars” Finalist Jack Osbourne Offers Inside Look at His Life with Multiple Sclerosis through You Don’t Know Jack About MS™ Campaign
December 04, 2013
from Business Wire News Releases
"Pay-for-delay" generic drug deals fall after EU crackdown
Today 8:01 EST
category companyNews
from Reuters: Company News
Teva bets on new therapeutic uses of known molecules
December 08, 2013
category companyNews
from Reuters: Company News
Streetinsider.com's Hot Lunchtime Reads 12/06: (P) (BKS) (FRX) (CNP) (KNDI)
December 06, 2013
from StreetInsider.com News Articles
Teva (TEVA) Sues Forest Labs (FRX) Over Alzheimer's Disease Drug
December 06, 2013
from StreetInsider.com News Articles
New factory puts Iceland in biosimilar drugs race
December 04, 2013
category companyNews
from Reuters: Company News
Orphan Drug Designations, Invitations to Investors Conferences, and Stock Price updates - Research Report on Teva, Cubist, Community Health Systems, Aegerion, and Air Methods
December 06, 2013
from PR Newswire
Teva seeks deals to build drug portfolio, 2014 outlook next week
December 04, 2013
category companyNews
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here